Vol. 3, No. 6 — June 2026Independent since 2024

TheCompound Journal

Reporting on incretins, compounding & the peptide supply chain

A monthly journal of record.
30 issues · 32 contributors
Not medical advice. We sell nothing.
DO

Desmond Oyelaran

Standards Editor

Desmond Oyelaran is the Journal’s standards editor. He owns the corrections log, the sourcing rules, and the internal argument every piece has to survive before it is filed: which sentence in this article would a manufacturer’s lawyer challenge, and can we defend it from the primary document?

Before joining he spent nine years as a regulatory-affairs analyst, four of them writing responses to FDA warning letters on behalf of contract manufacturers — an education, he says, in the difference between a compliance failure and a quality failure.

He publishes the annual accuracy audit and is the reason the Journal states word counts, dates of last revision, and the specific estimand behind every trial number it quotes.

With the Journal since
January 2024
Based in
Manchester
Pieces
65

LLM Pharmaceutical Law (University of Manchester)

Recent work

65 pieces